Article Sidebar

Submitted
Apr 21, 2021
Published
Apr 21, 2021
Download
PDF
Statistic
Read Counter : 32 Download : 24

Main Article Content

Abstract

Dengue virus infection is a serious health problem infecting 2.5 billion people worldwide. Dengue virus belongs to family Flaviviridae, having four serotypes that spread by the bite of infected Aedesmosquitoes. It causes a wide spectrum of illness from mild asymptomatic illness to severe fatal dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). The relationship of this country with dengue has been long and intense. The first recorded epidemic of clinically dengue like illness occurred at Madras in 1780 and the dengue virus was isolated for the first time almost simultaneously in Japan and Calcutta in 1943–1944. After the first virologically proved epidemic of dengue fever along the East Coast of India in 1963–1964, it spread to allover the country. The first full-blown epidemic of the severe form of the illness, the dengue haemorrhagic fever/ dengue shock syndrome occurred in North India in 1996. Aedesaegyptiis the vector for transmission of the disease. Vaccines or antiviral drugs are not available for dengue viruses; the only effective way to prevent epidemic dengue fever/dengue haemorrhagic fever (DF/DHF) is to control the mosquito vector, Aedesaegypti and prevent its bite. This country has few virus laboratories and some of them have done excellent work in the area of molecular epidemiology, immunopathology and vaccine development. Selected work done in this country on the problems of dengue is presented here. Dengue fever is a re-emergent and challenging public health problem in the world. In this review we will give an overview of the infectious DENV and will discuss the viral and host factors that are important in controlling DENV  infection.

Keywords

Dengue fever Viral infection Biochemical screening

Article Details

How to Cite
Shameemunnisa S.A.K, & Agnes jenitha X. (2021). Biochemical screening of dengue fever. International Journal of Research in Pharmacology & Pharmacotherapeutics, 4(2), 276-287. https://doi.org/10.61096/ijrpp.v4.iss2.2015.276-287
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1] World Health Organization, Dengue: guidelines for diagnosis, treatment, prevention and control.WHO, 2nd edition, 2009.
  2. [2] Simmons CP, Chau TN, Thuy TT, Tuan NM, Hoang DM, Thien NT, Lien lB, QuyNT, Hieu NT, Hien TT, McElnea C, Young P, Whitehead S, Hung NT, Farrar J (2007) Maternal antibody and viral factors in the pathogenesis of dengue virus in infants. J Infect Dis 196:416–424.
  3. [3] Whitehorn J, Farrar J (2010). "Dengue". Br.Med.Bull. 95: 161–73. doi:10.1093/bmb/ldq019. PMID 20616106.
  4. [4] SoundravallyR, Sankar P, Hoti SL, Selvaraj N, Bobby Z, Sridhar MG. Oxidative stress induced changes in plasma protein can be a predictor of imminent severe dengue infection. Acta Trop 2008; 106: 156-61.
  5. [5] Anoop M, Issac A, Mathew T, Philip S, Kareem NA, and Unnikrishnan R (2010), Genetic characterization of dengue virus serotypes causing concurrent infection in an outbreak in Ernakulam, Kerala, South India. Indian J.Exp Biol; 48:849-57
  6. [6] Souza LJ, Nogueira RMR, Soares LC, Soares CEC, Ribas BF, Alves FP, et al. The Impact of Dengue on Liver Function as Evaluated by Aminotransferase Levels. Braz J Infect Dis 2007; 11(4): 407-10.
  7. [7] Ghosh K, Gangodkar S, Jain P, Shetty S, Ramjee S, and Poddar P (2008), Imaging the interaction between dengue 2 virus and human platelets using atomic force and electron microscopy; J.Electron Microsc; 57:113-8
  8. [8] Claro, L.B;Tomassini,H.C.and Rosa,M.L;2004.Dengue prevention and control: A review of studies on knowledge, beliefs and practices. Cadernas de saudepublica;20(6):1447-145.
  9. [9] Hedin SG."TheHaematokrit: a New Apparatus for the Investigation of Blood". Skandinavisches Archivfür Physiologie 2: 134–140,1891.
  10. [10] Gurugama P, Garg P, Perera J, Wijewickrama A, Seneviratne SL: Dengue viral infections. Indian J Dermatol2010; 55(1): 68-78.
  11. [11] da Silvavoorham AM, Dittus WP, Amerasinghe PH, Amerasinghe FP. Serologic evidence for an epizootic dengue virus infecting toque macaques (Macacasinica) at Polonnaruwa, Sri Lanka. Am J Trop Med Hyg. 2009; Feb; 60(2): 300–306.
  12. [12] Coller,B.A.,Clements.D.E., Martyak,T.,Yelmene, Thorne,M. and Parks,D.E;2010.Advances in falvi virus vaccine development. Drugs;13(12):880-4.
  13. [13] Pandey BD, Rai SK, Morita K KuraneI. First case of dengue virus in Techu in Nepal. Nepal Coll. J. 2004Dec; 6(2): 157–159.
  14. [14] Lum LC, Lam SK, George R, Devi S. Fulminant hepatitis in dengue infection.Southeast Asian J Trop Med Public Health 1995;24:467–71.
  15. [15] Roy A, Sarkar D, Chakraborty S, Chaudhuri J, Ghosh P: Profile of hepaticinvolvement by dengue virus in dengue infected children. N Am J Med Sci 2013; 5:480–485.
  16. [16] Bhatty S, Shaikh NA, Fatima M, Sumbhuani AK: Acute acalculouscholecystitis in dengue fever. J Pak Med Assoc 2009; 59:519–521.
  17. [17] Harries,A.D.,Maher,D.and Raviglione,M.C;2001.Report on global surveillence of Epidemic-prone infectious disease.Geneva:WHO;2:69-70.
  18. [18] de Souza LJ, GoncalvesCarneiro H, SoutoFilho JT, Ferreira de Souza T, Azevedo Cortes V, Neto CG, BastosAssed D, Wallace da Silva Siqueira E (2002) Hepatitis in dengue shock syndrome. Braz J Infect Dis 6: 322-327.
  19. [19] Jusuf H, Sudjana P, Djumhana A, Abdurachman SA, 1998. DHFwith complication of acute pancreatitis related hyperglycemia:a case report. Southeast Asian J Trop Med Public Health 29:367–369.
  20. [20] Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, SuntayakornS, Kunentrasai N, Viramitrachi W, Ratanachu-eke S, KiatpolpojS, Innis BL, Rothman AL, Nisalak A, Ennis FA, 1997.Early clinical and laboratory indicators of acute dengue illness.J Infect Dis 176: 313–321.
  21. [21] Kumar R, Tripathi P, Tripathi S, Kanodia A, Venkatesh V (2008) Prevalence of dengue infection in north Indian children with acute hepatic failure. Ann Hepatol 7: 59-62.
  22. [22] Husain FA, Martin MJ, Mullenix PS, Steele SR, Elliott DC. Serum lactate and base deficit as predictors of mortality and morbidity. Am J Surg. 2003;185:485–91.
  23. [23] Howell MD, Donnino M, Clardy P, Talmor D, Shapiro NI. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med. 2007;33:1892–9.
  24. [24] Nguyen TL, Nguyen TH, Tieu NT, 1997. The impact of denguehemorrhagic fever on liver function. Res Virol 148: 273–277.
  25. [25] Gulati S and Maheshwari A (2007) Atypical manifestations of dengue. Trop Med Int Health 12: 1087-1095.
  26. [26] Franco-Paredes C, Jacob JT, Hidron A, Rodriguez-Morales AJ, Kuhar D, Caliendo AM: Transplantation and tropical infectious diseases. Int J Infect Dis 2010, 14:e189-e196
  27. [27] Wilder-Smith A, Schwartz E. Dengue in travelers. N Engl J Med2004; 353:924–32.